ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Clinical trials for ESOPHAGEAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ESOPHAGEAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for ESOPHAGEAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising drug cocktail aims to wipe out esophageal tumors before surgery
Disease control Not yet recruitingThis study tests whether giving a combination of three drugs (camrelizumab, chemotherapy, and ivarmacitinib) before surgery can improve outcomes for people with a type of esophageal cancer. About 45 adults with stage II to IVA esophageal squamous cell carcinoma will receive this …
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated May 26, 2026 05:04 UTC
-
New drug cocktail aims to shrink esophageal tumors in First-Line fight
Disease control Not yet recruitingThis study tests whether a new combination of drugs (SYS6010 and SG001), with or without standard chemotherapy, can shrink tumors and help people with advanced esophageal cancer live longer. About 737 adults who have not had prior treatment for their advanced cancer will take par…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd. • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
New hope for advanced esophageal cancer: triple therapy trial launches
Disease control Not yet recruitingThis study tests a new drug, BL-B01D1, combined with tislelizumab (with or without 5-FU) against standard chemotherapy plus tislelizumab for people with advanced esophageal cancer that cannot be removed by surgery. About 90 adults will participate. The goal is to see if the new c…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 04:35 UTC
-
New drug combo shows promise against tough esophageal cancer
Disease control Not yet recruitingThis study tests whether adding the experimental drug Ivonescimab to standard chemotherapy before surgery can improve outcomes for people with resectable esophageal squamous cell carcinoma. About 49 adults with stage II to IVA cancer will receive the combination, then have surger…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
Morning or afternoon? timing may boost cancer therapy
Disease control Not yet recruitingThis study looks at whether giving immunotherapy at different times of day changes how well it works for people with a type of esophageal cancer. About 90 patients will be split into three groups based on when they receive their infusion (morning vs. afternoon). The goal is to se…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
New shot for tough esophageal cancer enters first human tests
Disease control Not yet recruitingThis early-phase study tests a new drug called IPM514 in people with advanced esophageal cancer that has spread or come back. The main goal is to see if the drug is safe and to find the best dose. About 36 adults will receive the drug as a shot, with doses increasing in small gro…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Beijing Immupeutics Medicine Technology Limited • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
Scientists to map tumor changes after Chemo-Immunotherapy in esophageal cancer
Knowledge-focused Not yet recruitingThis study looks at how the area around esophageal tumors changes after standard chemotherapy combined with immunotherapy and before surgery. Researchers will collect tumor samples before and after treatment from 12 participants and use advanced genetic tools to study cell change…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Sponsor: Nanjing Medical University • Aim: Knowledge-focused
Last updated May 26, 2026 05:05 UTC
-
New study aims to make allergy testing safer for cancer patients on biologics
Knowledge-focused Not yet recruitingThis study looks at how to safely test for allergic reactions to biotherapy drugs in cancer patients. Researchers will find the highest skin test dose that does not cause irritation in most people. The goal is to create clear guidelines for doctors to diagnose allergies to these …
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: University Hospital, Angers • Aim: Knowledge-focused
Last updated May 22, 2026 13:54 UTC